Association of pro-inflammatory and anti-inflammatory cytokine polymorphisms with COVID-19 severity in unvaccinated patients

Связь полиморфизмов провоспалительных и противовоспалительных цитокинов с тяжестью COVID-19 у невакцинированных пациентов
Carlos Pineda, Gilberto Vargas‐Alarcón, Paola Vázquez-Cárdenas, Maylin Almonte‐Becerril, Ivette Cruz‐Bautista, Leslie Chávez‐Galán, Julio Flores‐González, Gabriela Angélica Martínez‐Nava, Laura E. Martínez-Gómez, Carla Isabel Oropeza-Vélez, Carlos Martínez-Armenta, Rosa P. Vidal-Vázquez, Juan Pablo Ramírez-Hinojosa, Diana Gómez‐Martín, José Manuel Rodrı́guez-Pérez, Lucero A. Ramón‐Luing, José A. Carrasco, Mónica Maribel Mata-Miranda, Gustavo Jesús Vázquez-Zapién, Adriana Martínez-Cuazitl, Nancy Torres, Felipe de J. Martínez-Ruiz, Dulce M. Zayago-Angeles, Ma. Luisa Ordoñez-Sánchez, Yayoi Segura-Kato, Carlos Suárez-Ahedo, Jessel Olea-Torres, Brígida Herrera-López, Alberto López-Reyes
2025-08-13

CCL5 rs2107538IL-10 rs1800871IL-10 rs1800872TNFα rs1800629cytokine storm
Background Cytokines and chemokines are essential for establishing an appropriate immune response to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Variations in the genes encoding cytokines and chemokines strongly influence the immune response to pathogenic challenges and disease outcomes. This study was conducted to investigate the associations between polymorphisms in the TNF-α, IL-6, IL-8, IL-10, and CCL5 genes and COVID-19 severity. Methodology We performed a cross-sectional study with a total of 627 unvaccinated COVID-19 patients were classified according to WHO disease severity. We evaluated the levels of IFN-α, IFN-γ, TNF-α, IL-1Ra, IL-2, IL-6, IL-7, IL-10, CCL2, CCL3, CXCL8, CXCL10 and GCSF in the serum and compared them among COVID-19 severity groups by Kruskal-Wallis test and stratified by polymorphism alleles. A logistic regression was performed to determine the association of the polymorphism and COVID-19 severity. Results This study revealed a significant increase in IL-2, IL-6 and CCL-2 levels in the deceased group. However, the IL-10 levels were higher in the moderate group than in the mild group. Logistic regression analysis revealed that five polymorphisms were associated with a higher risk of severe COVID-19: the TNF-α (rs1800610) A allele (OR=1.50; 95% CI: 1.01–2.24); the IL-6 (rs1800796) C allele (OR=1.64; 95% CI: 1.05–2.57); the IL-10 (rs1800871) T allele (OR=1.94; 95% CI: 1.24–3.04) and (rs1800872) A allele (OR=1.87; 95% CI: 1.21–2.89); and the CCL5 (rs3817656) G allele (OR= 1.64; 95% CI: 1.02–2.65). Conclusion Patients infected with SARS-CoV-2 who have the TNFα gene variant (rs1800629) are protected from developing COVID-19 moderate and severe outcomes, as well as from presenting low concentrations of some pro-inflammatory cytokines and chemokines. However, carriers of the IL-10 (rs1800872, rs1800871) and CCL-5 (rs2107538) gene variants were associated with patients who died from COVID-19. Of these, only the minor allele of CCL-5 was primarily associated with increased chemokines levels, as well as with some cytokines considered hallmarks of the cytokine storm.
1
Carriers of IL-10 gene variants rs1800872 and rs1800871 are associated with COVID-19 mortality.
2
Carriers of the CCL-5 gene variant rs2107538 are associated with COVID-19 mortality.
3
Carriers of the TNFα gene variant rs1800629 are protected from developing moderate and severe COVID-19 outcomes in unvaccinated patients.
4
TNFα rs1800629 carriers show protection from presenting low concentrations of some pro-inflammatory cytokines and chemokines.
5
The minor allele of CCL-5 rs2107538 is primarily associated with increased chemokine levels and elevated cytokines characteristic of the cytokine storm.

Unvaccinated patients infected with SARS-CoV-2 (COVID-19 patients)

Association between pro- and anti-inflammatory cytokine and chemokine gene polymorphisms (TNFα rs1800629, IL-10 rs1800872/rs1800871, CCL5 rs2107538) and COVID-19 severity, mortality, and circulating cytokine/chemokine levels

Publication Details
Publication Date
2025-08-13
Journal
Publisher
ISSN
Cited by
4
Access Type
Author Information
Authors
Carlos Pineda
Gilberto Vargas‐Alarcón
Paola Vázquez-Cárdenas
Maylin Almonte‐Becerril
Ivette Cruz‐Bautista
Leslie Chávez‐Galán
Julio Flores‐González
Gabriela Angélica Martínez‐Nava
Laura E. Martínez-Gómez
Carla Isabel Oropeza-Vélez
Carlos Martínez-Armenta
Rosa P. Vidal-Vázquez
Juan Pablo Ramírez-Hinojosa
Diana Gómez‐Martín
José Manuel Rodrı́guez-Pérez
Lucero A. Ramón‐Luing
José A. Carrasco
Mónica Maribel Mata-Miranda
Gustavo Jesús Vázquez-Zapién
Adriana Martínez-Cuazitl
Nancy Torres
Felipe de J. Martínez-Ruiz
Dulce M. Zayago-Angeles
Ma. Luisa Ordoñez-Sánchez
Yayoi Segura-Kato
Carlos Suárez-Ahedo
Jessel Olea-Torres
Brígida Herrera-López
Alberto López-Reyes
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat
Make a presentation
100%